Current location - Recipe Complete Network - Complete breakfast recipes - Has the gsp certification of veterinary drugs been cancelled?
Has the gsp certification of veterinary drugs been cancelled?
Legal analysis: The newly revised Drug Administration Law of People's Republic of China (PRC) was voted by the 12th meeting of the 13th the National People's Congress Standing Committee (NPCSC), and will be implemented on June 20 19 +20 1 day, confirming the cancellation of GMP/GSP certification.

The content specified by GMP is the most basic condition that pharmaceutical processing enterprises must meet. The international concept of drugs includes veterinary drugs. Only a few countries, such as China and Australia, separate GMP of drugs for human use from GMP of veterinary drugs. However, relevant sources said that on the whole, most of the GMP upgrades of veterinary drugs in China were modified in the GMP of human drugs. The promulgation of the new Drug Administration Law may have an impact on the way and intensity of veterinary drug supervision.

Legal basis: Drug Administration Law of People's Republic of China (PRC).

Article 1 This Law is formulated with a view to strengthening drug administration, ensuring drug quality, safeguarding the safety and legitimate rights and interests of the public in drug use, and protecting and promoting public health.

Article 2 This Law shall apply to the research, production, trading, use, supervision and administration of drugs within the territory of People's Republic of China (PRC).

Drugs mentioned in this Law refer to substances used for preventing, treating and diagnosing human diseases, purposefully regulating human physiological functions, and specifying indications or functional indications, usage and dosage, including traditional Chinese medicines, chemicals and biological products.

Article 3 Drug management should focus on people's health, adhere to the principles of risk management, whole-process control and social governance, establish a scientific and strict supervision and management system, comprehensively improve drug quality, and ensure drug safety, effectiveness and accessibility.